Balyasny Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $106M | Buy |
1,534,751
+1,227,342
| +399% | +$84.7M | 0.16% | 103 |
|
|
2025
Q1 | $21.3M | Sell |
307,409
-420,105
| -58% | -$29.2M | 0.04% | 423 |
|
|
2024
Q4 | $62.6M | Buy |
727,514
+202,223
| +38% | +$17.4M | 0.09% | 191 |
|
|
2024
Q3 | $62.5M | Buy |
525,291
+141,647
| +37% | +$16.9M | 0.1% | 173 |
|
|
2024
Q2 | $54.8M | Buy |
+383,644
| New | +$54.8M | 0.1% | 210 |
|
|
2024
Q1 | – | Sell |
-403,673
| Closed | -$41.8M | – | 2289 |
|
|
2023
Q4 | $41.8M | Buy |
+403,673
| New | +$41.8M | 0.08% | 232 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 2066 |
|
|
2023
Q2 | – | Sell |
-209,098
| Closed | -$16.6M | – | 2159 |
|
|
2023
Q1 | $16.6M | Buy |
+209,098
| New | +$16.6M | 0.04% | 468 |
|
|
2021
Q3 | – | Sell |
-374,192
| Closed | -$15.7M | – | 1966 |
|
|
2021
Q2 | $15.7M | Buy |
+374,192
| New | +$15.7M | 0.07% | 331 |
|
|
2020
Q3 | – | Sell |
-725,616
| Closed | -$23.8M | – | 1264 |
|
|
2020
Q2 | $23.8M | Sell |
725,616
-208,840
| -22% | -$6.84M | 0.21% | 114 |
|
|
2020
Q1 | $28.1M | Sell |
934,456
-459,528
| -33% | -$13.8M | 0.33% | 66 |
|
|
2019
Q4 | $40.3M | Sell |
1,393,984
-475,736
| -25% | -$13.8M | 0.24% | 106 |
|
|
2019
Q3 | $48.3M | Buy |
1,869,720
+1,313,966
| +236% | +$34M | 0.33% | 62 |
|
|
2019
Q2 | $14.2M | Buy |
555,754
+289,080
| +108% | +$7.38M | 0.09% | 276 |
|
|
2019
Q1 | $6.98M | Sell |
266,674
-256,526
| -49% | -$6.71M | 0.05% | 429 |
|
|
2018
Q4 | $12.1M | Sell |
523,200
-53,284
| -9% | -$1.23M | 0.09% | 286 |
|
|
2018
Q3 | $13.6M | Sell |
576,484
-198,212
| -26% | -$4.67M | 0.06% | 338 |
|
|
2018
Q2 | $17.9M | Buy |
774,696
+181,136
| +31% | +$4.18M | 0.08% | 292 |
|
|
2018
Q1 | $14.6M | Buy |
+593,560
| New | +$14.6M | 0.06% | 355 |
|